Stay updated on NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.

Latest updates to the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew trial locations were added (Barcelona, Gran Canaria, La Coruña, Madrid, Pontevedra, Vizcaya) and existing location blocks were removed to reflect updated site availability for NADIM II.SummaryDifference0.6%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. No changes to study content or page layout were observed.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all relate to the study, and updated the revision to v3.3.1.SummaryDifference0.1%

- Check50 days agoChange DetectedThe government funding notice was removed from the page. Core study details, locations, and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check64 days agoChange DetectedNo significant additions or deletions were detected; the NADIM II study page content and layout remain unchanged.SummaryDifference0.4%

- Check93 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.